0I8F.L - DENTSPLY SIRONA Inc.
| Previous close | 36.47 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 1,293 |
| Market cap | 87.678M |
| Beta (5Y monthly) | 0.92 |
| PE ratio (TTM) | 0.22 |
| EPS (TTM) | 1.68 |
| Earnings date | 02 Aug 2023 - 07 Aug 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksHere's Why Dentsply (XRAY) Is a Great 'Buy the Bottom' Stock Now
After losing some value lately, a hammer chart pattern has been formed for Dentsply (XRAY), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
ZacksHere's Why You Should Retain DENTSPLY SIRONA (XRAY) Stock
DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.
ZacksDown -7.13% in 4 Weeks, Here's Why You Should You Buy the Dip in Dentsply (XRAY)
The heavy selling pressure might have exhausted for Dentsply (XRAY) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
ZacksDENTSPLY SIRONA (XRAY) Q1 Earnings & Revenues Beat Estimates
DENTSPLY SIRONA's (XRAY) Q1 earnings and revenues decline year over year, driven by the unfavorable foreign currency movement and soft demand across all geographical segments.
ZacksCompared to Estimates, Dentsply (XRAY) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Dentsply (XRAY) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ZacksWhat's in Store for DENTSPLY SIRONA (XRAY) in Q1 Earnings?
DENTSPLY SIRONA's (XRAY) first-quarter 2023 results are likely to reflect strong performance in the Technologies & Equipment business.
ZacksHere's Why You Should Retain DENTSPLY SIRONA (XRAY) Stock Now
DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.
ZacksDENTSPLY SIRONA (XRAY) Q4 Earnings & Revenues Beat Estimates
DENTSPLY SIRONA's (XRAY) Q4 earnings and revenues decline year over year due to unfavorable foreign currency movement and soft demand across all geographical segments.
ZacksWhat's in Store for DENTSPLY SIRONA (XRAY) in Q4 Earnings?
DENTSPLY SIRONA's (XRAY) fourth-quarter results are likely to reflect strong performance in the Technologies & Equipment business.
- Zacks
DENTSPLY SIRONA's (XRAY) Preliminary FY22 Sales Meet Estimates
DENTSPLY SIRONA's (XRAY) preliminary results meet market expectation. While certain product categories are driving growth, macro headwinds continue to hurt the top line.
ZacksWhy Is Dentsply (XRAY) Up 1% Since Last Earnings Report?
Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksDENTSPLY SIRONA (XRAY) Q3 Earnings & Revenues Miss Estimates
Despite a year-over-year decline in both earnings and revenues, DENTSPLY SIRONA's (XRAY) third-quarter results benefit from the Technologies & Equipment business.
ZacksWhat's in Store for DENTSPLY SIRONA (XRAY) in Q3 Earnings?
DENTSPLY SIRONA's (XRAY) third-quarter results are likely to reflect strong performance in the Technologies & Equipment business.
ZacksDexCom and Papa John's International have been highlighted as Zacks Bull and Bear of the Day
DexCom and Papa John's International are part of the Zacks Bull and Bear of the Day article.
Zacks3 Stocks From the Growing Digital Orthodontic Space in Focus
The orthodontic treatment market has experienced substantial recovery, primarily owing to the easing of restrictions and mass opening up of the economy in 2022.
- Zacks
DENTSPLY SIRONA (XRAY) Falls After Nasdaq's Delinquency Notice
The Nasdaq exchange issues a notice to DENTSPLY SIRONA (XRAY) for filing delinquency from the exchange and for non-compliance with the Nasdaq Listing Rules. Shares fall.
ZacksDENTSPLY SIRONA (XRAY) Up on Strong Q2 Preliminary Results
DENTSPLY SIRONA's (XRAY) preliminary second-quarter 2022 results reflect the normalizing business, aided by product launches and pricing adjustments. Shares rise.
- Zacks
Here's Why You Should Buy DENTSPLY SIRONA (XRAY) Stock Now
DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woes persist.
ZacksIs McKesson (MCK) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
ZacksWhy Is Dentsply (XRAY) Up 6.2% Since Last Earnings Report?
Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.